2025-04-08 17:37:17
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Mangalam Drugs and Organics Ltd Q2FY22 PAT up at Rs. 4.52 crore
Posted On : 2021-11-19 20:26:32( TIMEZONE : IST )
Mangalam Drugs And Organics Limited has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 123.0233 crores during the period ended September 30, 2021 as compared to Rs. 105.3007 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 4.5281 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 4.4158 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 2.86 for the period ended September 30, 2021 as compared to Rs. 2.79 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 123.0233 crs | ₹105.3007 crs |  16.83% |
| Net Profit | ₹4.5281 crs | ₹4.4158 crs | 2.54% |
| EPS | ₹2.86 | ₹2.79 | 2.51% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 123.0233 crores during the period ended September 30, 2021 as compared to Rs.97.7099 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.4.5281 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.11.0870 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.2.86 for the period ended September 30, 2021 as compared to Rs.7.00 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 123.0233 crs | ₹97.7099 crs | 25.91% |
| Net Profit | ₹4.5281 crs | ₹11.0870 crs |  -59.16% |
| EPS | ₹2.86 | ₹7.00 | -59.14% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.228.3240 crores during the 6 Months period ended September 30, 2021 as compared to Rs.202.0053 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.8.9439 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.19.3825 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.5.65 for the 6 Months period ended September 30, 2021 as compared to Rs.12.25 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹228.3240 crs | ₹202.0053 crs | 13.03% |
| Net Profit | ₹8.9439 crs | ₹19.3825 crs | -53.86% |
| EPS | ₹5.65 | ₹12.25 | -53.88% |
Shares of Mangalam Drugs And Organics Limited was last trading in BSE at Rs. 127.50 as compared to the previous close of Rs. 130.75. The total number of shares traded during the day was 5038 in over 181 trades.
The stock hit an intraday high of Rs. 132.00 and intraday low of 127.45. The net turnover during the day was Rs. 647576.00.
